The DOI matches its Crossref record.
B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
Abstract
The characterization of a new B cell-specific antigen (B4) is described in this report. With the use of a monoclonal antibody to B4, it was shown that B4 is present on B cells isolated from peripheral blood and lymphoid organs, on cell lines derived from normal and malignant B cells, and on tumor cells isolated from patients with B cell-derived neoplasms. B4, in contrast, was not detected on normal, activated, or malignant cells of T or myeloid origin. The B4 antigen is distinct from known B cell antigens, including sIg, Ia, B1, B2, Fc, and C3. Examination of mitogen-stimulated B lymphocytes suggests that the B4 antigen initially increases with B cell activation and then is lost at the terminal stage of B cell differentiation. Moreover, the observation that B4 is expressed on almost all early B cell tumors suggests that it may precede B1, CALLA, cytoplasmic mu, and B2 in early B cell ontogeny.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Stein, H., Mason, D., Gerdes, J., O'Connor, N., Wainscoat, J., Pallesen, G., Gatter, K., Falini, B., Delsol, G., Lemke, H., et al. (1985) · Blood · doi:10.1182/blood.v66.4.848.848 · Cited by 1,846
Kochenderfer, J. N., Wilson, W. H., Janik, J. E., Dudley, M. E., Stetler-Stevenson, M., Feldman, S. A., Maric, I., Raffeld, M., Nathan, D.-A. N., Lanier, B. J., et al. (2010) · Blood · doi:10.1182/blood-2010-04-281931 · Cited by 1,337
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., et al. (1996) · Nature · doi:10.1038/379645a0 · Cited by 897
Imai, C., Mihara, K., Andreansky, M., Nicholson, I. C., Pui, C.-H., Geiger, T. L., & Campana, D. (2004) · Leukemia · doi:10.1038/sj.leu.2403302 · Cited by 840
Anderson, K., Bates, M., Slaughenhoupt, B., Pinkus, G., Schlossman, S., & Nadler, L. (1984) · Blood · doi:10.1182/blood.v63.6.1424.1424 · Cited by 704
Self-citationCD19: Lowering the Threshold for Antigen Receptor Stimulation of B Lymphocytes
Carter, R. H., & Fearon, D. T. (1992) · Science · doi:10.1126/science.1373518 · Cited by 674
Engel, P., Zhou, L.-J., Ord, D. C., Sato, S., Koller, B., & Tedder, T. F. (1995) · Immunity · doi:10.1016/1074-7613(95)90157-4 · Cited by 541
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
Kochenderfer, J. N., & Rosenberg, S. A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.46 · Cited by 451
Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development
Loken, M., Shah, V., Dattilio, K., & Civin, C. (1987) · Blood · doi:10.1182/blood.v70.5.1316.1316 · Cited by 442
Thompson, J. A., Schneider, B. J., Brahmer, J., Achufusi, A., Armand, P., Berkenstock, M. K., Bhatia, S., Budde, L. E., Chokshi, S., Davies, M., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0020 · Cited by 426
Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen Receptor
Kochenderfer, J. N., Feldman, S. A., Zhao, Y., Xu, H., Black, M. A., Morgan, R. A., Wilson, W. H., & Rosenberg, S. A. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181ac6138 · Cited by 408
Kochenderfer, J. N., Yu, Z., Frasheri, D., Restifo, N. P., & Rosenberg, S. A. (2010) · Blood · doi:10.1182/blood-2010-01-265041 · Cited by 391
Nemerow, G. R., Wolfert, R., McNaughton, M. E., & Cooper, N. R. (1985) · Journal of Virology · doi:10.1128/jvi.55.2.347-351.1985 · Cited by 344
Stong, R., Korsmeyer, S., Parkin, J., Arthur, D., & Kersey, J. (1985) · Blood · doi:10.1182/blood.v65.1.21.21 · Cited by 327
The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP.
Kozmik, Z., Wang, S., Dörfler, P., Adams, B., & Busslinger, M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.6.2662 · Cited by 325
CD19 Antigen in Leukemia and Lymphoma Diagnosis and Immunotherapy
Scheuermann, R. H., & Racila, E. (1995) · Leukemia & Lymphoma · doi:10.3109/10428199509059636 · Cited by 323
CD19 of B Cells as a Surrogate Kinase Insert Region to Bind Phosphatidylinositol 3-Kinase
Tuveson, D. A., Carter, R. H., Soltoff, S. P., & Fearon, D. T. (1993) · Science · doi:10.1126/science.7684160 · Cited by 322
Kipps, T. J. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60663-x · Cited by 321
Evidence for a Large Compartment of IgM-Expressing Memory B Cells in Humans
Klein, U., Küppers, R., & Rajewsky, K. (1997) · Blood · doi:10.1182/blood.v89.4.1288 · Cited by 315
Nadler, L. M., Korsmeyer, S. J., Anderson, K. C., Boyd, A. W., Slaughenhoupt, B., Park, E., Jensen, J., Coral, F., Mayer, R. J., & Sallan, S. E. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111428 · Cited by 308
Self-citationMatsumoto, A. K., Kopicky-Burd, J., Carter, R. H., Tuveson, D. A., Tedder, T. F., & Fearon, D. T. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.1.55 · Cited by 305
Recombinant Toxins for Cancer Treatment
Pastan, I., & FitzGerald, D. (1991) · Science · doi:10.1126/science.1683495 · Cited by 299
Goodwin, R. G., Lupton, S., Schmierer, A., Hjerrild, K. J., Jerzy, R., Clevenger, W., Gillis, S., Cosman, D., & Namen, A. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.302 · Cited by 287
Maes, M., Lambrechts, J., Bosmans, E., Jacobs, J., Suy, E., Vandervorst, C., De Jonckheere, C., Minner, B., & Raus, J. (1992) · Psychological Medicine · doi:10.1017/s0033291700032712 · Cited by 275
Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases
Uckun, F. M., Evans, W. E., Forsyth, C. J., Waddick, K. G., Tuel-Ahlgren, L., Chelstrom, L. M., Burkhardt, A., Bolen, J., & Myers, D. E. (1995) · Science · doi:10.1126/science.7531365 · Cited by 271
Metadata
- Authors
- Nadler, L. M., Anderson, K. C., Marti, G., Bates, M., Park, E., Daley, J. F., & Schlossman, S. F.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1983-07-01
- Volume
- 131
- Issue
- 1
- Pages
- 244-250
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1548735291
- Cited by
- 486
- References
- 0
- FWCI
- 13.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.